SEC Form 4 · accession 0001415889-16-005148
ACADIA PHARMACEUTICALS INC · ACAD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Davis
Officer — PRESIDENT AND CEO · Director
Period of report
Mar 15, 2016
Accepted (ET)
Mar 17, 2016 · 6:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070494
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $19.65 | Mar 15, 2016 | A | 600,000 | A | — | Mar 14, 2026 | Common Stock | 600,000 | 600,000 | D |
Explanation of responses
- F125% of the shares subject to the Stock Option vest and become exercisable on March 15, 2017. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.